BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 31, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Digital cancer cells illustration

Varian injects $10M in Cota to fuel data-driven cancer care

Nov. 11, 2020
By Meg Bryant
Varian Medical Systems Inc. has invested $10 million in and inked a collaboration agreement with Cota Inc., a Boston-based curator of oncology clinical data. The radiation oncology company will now offer its customers access to Cota’s oncology real-world analytics and data curation services, which aggregate electronic health record (EHR) data to yield meaningful insights.
Read More
Regulatory front

ICER adjusts Veklury price models – again

Nov. 11, 2020
By Mari Serebrov
The latest global regulatory news, changes and updates affecting biopharma, including: MHRA advises on minimizing trial disruptions.
Read More

Regulatory actions for Nov. 11, 2020

Nov. 11, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Angiocrine, Bioxcel, Gyroscope, Inventiva, Sebela, Sorrento, Surface.
Read More

Other news to note for Nov. 11, 2020

Nov. 11, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agenus, Adaptive, Alcresta, Biontech, Biovaxys, Curis, Glaxosmithkline, Hebecell, Immuron Intellia, Myokardia, Nanoviricides, Oncimmune, Origimed, Parexel, PDS, Pfizer, Proteintech, Puretech, Recce, Reven, Revive, Takeda, Tiziana, Vapogenix, Xoma.
Read More

In the clinic for Nov. 11, 2020

Nov. 11, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AGTC, Ampio, Asieris, Blueberry, Cynata, Deciphera, Edgewise, Five Prime, Gyroscope, Henlius, Lineage, Lumos, Mesoblast, Oncternal, Pfizer, Prilenia, RDIF, Reven, Sagent, Xbrane.
Read More
Illustration of mouths coughing into hands

Quick cough tests reliably ID asymptomatic COVID-19, other conditions

Nov. 10, 2020
By Annette Boyle
As cases skyrocket and more questions arise about the high rate of false negatives returned by rapid testing in COVID-19 cases, a simple, new diagnostic test offers far greater accuracy. Researchers around the globe have found that artificial intelligence can detect coronavirus infections in recorded forced coughs, with nearly 100% accuracy in asymptomatic or presymptomatic cases, making it an ideal quick screening test. Forced cough or voice analysis shows strong results in other conditions, too, including pulmonary hypertension and, surprisingly, Alzheimer's disease.
Read More
Regulatory front

FDA announces class I recall of Stryker Trevo XP

Nov. 10, 2020
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: CDC updates vaccine guidance; Russia launches doctor-driven shortage reporting service.
Read More

Regulatory actions for Nov. 10, 2020

Nov. 10, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biocartis, Icotec, Materialise, Medcad.
Read More

Other news to note for Nov. 10, 2020

Nov. 10, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anpac Bio-Medical Science, Applied DNA Sciences, Argentum Medical, Ascendum Solutions, Beckman Coulter, Bone Therapeutics, Casetabs, Contakt World Technologies, Dnanudge, Exergen, Foshion Dental, GE Healthcare, Genesiscare, Genosity, GT Medical Technologies, Hologic, Hst Pathways Systems & Technologies, Igentify, Intervenn Biosciences, Iremedy Healthcare Companies, Logicink, Luxcreo, Oxford Immunotec Global, Penumbra, Precision Genetics, Promaxo, Rapid AI, Speedx, Tscan Therapeutics, Wheeler Labs.
Read More
Dollar sign droplet above test tube

R&D investments soar as biopharmas focus on therapies to tackle COVID-19

Nov. 10, 2020
By Peter Winter
According to an analysis conducted by BioWorld of the third-quarter 2020 financial reports filed by public biopharmaceutical companies with market caps greater than $1 billion, and excluding big pharma companies, the amount that was invested in research and development (R&D) during the nine-month period increased by almost 21% compared to the same period last year. The spending was bolstered by companies turning their attention to focus their research on therapies and vaccines to tackle COVID-19.
Read More
Previous 1 2 … 338 339 340 341 342 343 344 345 346 … 553 554 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 30, 2026.
  • Illustration of dopamine signaling in the brain

    New schizophrenia targets challenge trial design

    BioWorld
    The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 28, 2026
  • HIV virus

    AIDS 2026: New targets for metabolic dysfunction despite ART

    BioWorld
    Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
  • Lee-Cheng Liu, chairman, Taiwan BIO

    Taiwan biotech looks outward in next phase of growth

    BioWorld
    Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing